Levosimendan reverted severe pulmonary hypertension in one patient on waiting list for heart transplantation

Int J Cardiol. 2013 Oct;168(4):4518-9. doi: 10.1016/j.ijcard.2013.06.106. Epub 2013 Jul 19.

Authors

Enrico Ammirati¹, Francesco Musca, Fabrizio Oliva, Andrea Garascia, Valentina Pacher, Alessandro Verde, Manlio Cipriani, Antonella Moreo, Luigi Martinelli, Maria Frigerio

Affiliation

¹ Cardiothoracic and Vascular Department, Niguarda Ca' Granda Hospital, Milan, Italy; San Raffaele Scientific Institute and University, Milan, Italy. Electronic address: enrico.ammirati@ospedaleniguarda.it.

PMID: 23871623
DOI: 10.1016/j.ijcard.2013.06.106

No abstract available

Keywords: Heart failure; Heart transplantation; Levosimendan; Pulmonary hypertension; Right ventricle.

Publication types

Case Reports
Letter
Research Support, Non-U.S. Gov't

MeSH terms

Female
Heart Transplantation
Humans
Hydrazones / therapeutic use*
Hypertension, Pulmonary / drug therapy*
Pyridazines / therapeutic use*
Simendan
Vasodilator Agents / therapeutic use*
Waiting Lists
Young Adult

Substances

Hydrazones
Pyridazines
Vasodilator Agents
Simendan